Zacks.com on MSN4 小时
VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up
Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid, highly selective NaV1.8 pain signal inhibitor, suzetrigine, for the treatment of adults with moderate ...
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
EurekAlert!4 天
Preterm babies receive insufficient pain management
A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to ...
Putin lauds the strength of Russia’s war economy. Others see a mirage
Since Moscow’s full-scale invasion of Ukraine in 2022, Russia’s economy has surpassed expectations. But some experts say this ...